Cas9: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
[[Cas9]] is the RNA-guided [[DNA]] [[endonuclease]] used by the CRISPR (clustered regularly interspaced short palindromic repeats)-associated systems to generate double-strand DNA breaks in the invading DNA during an adaptive bacterial immune response. | [[Cas9]] is the RNA-guided [[DNA]] [[endonuclease]] used by the CRISPR (clustered regularly interspaced short palindromic repeats)-associated systems to generate double-strand DNA breaks in the invading DNA during an adaptive bacterial immune response. | ||
Seealso[[Cas9 (hebrew)]]. | |||
The CRISPR-associated endonuclease [[Cas9]] has been exploited for use in genome editing systems. In such systems, an engineered single-guide RNA (sgRNA) is used to target double-stranded breaks in genomic DNA. Depending on what repair pathway is triggered, often dictated by the inclusion of additional engineered components, the targeted site either is disrupted or incorporates additional genetic sequences. | The CRISPR-associated endonuclease [[Cas9]] has been exploited for use in genome editing systems. In such systems, an engineered single-guide RNA (sgRNA) is used to target double-stranded breaks in genomic DNA. Depending on what repair pathway is triggered, often dictated by the inclusion of additional engineered components, the targeted site either is disrupted or incorporates additional genetic sequences. |
Revision as of 13:20, 17 January 2022
Cas9 is the RNA-guided DNA endonuclease used by the CRISPR (clustered regularly interspaced short palindromic repeats)-associated systems to generate double-strand DNA breaks in the invading DNA during an adaptive bacterial immune response.
SeealsoCas9 (hebrew).
The CRISPR-associated endonuclease Cas9 has been exploited for use in genome editing systems. In such systems, an engineered single-guide RNA (sgRNA) is used to target double-stranded breaks in genomic DNA. Depending on what repair pathway is triggered, often dictated by the inclusion of additional engineered components, the targeted site either is disrupted or incorporates additional genetic sequences.
Microbiologist and 2020 Nobel laureate Emanuelle Charpentier, from Max Planck Institute for Infection Biology in Berlin, is one of the co-inventors of the groundbreaking
This video, by Paul Andersen, explains how the CRISPR/Cas immune system
was identified in bacteria and how the CRISPR/Cas9 system was developed to edit genomes.
a powerful new technology with many applications in biomedical research,
including the potential to treat human genetic disease.
Articles in Proteopedia concerning Cas9 include:
3D structures of Cas93D structures of Cas9

Streptococcus pyogenes Cas9Streptococcus pyogenes Cas9
- 4un3, 4un4, and 4un5 - S. pyogenes Cas9 bound to sgRNA and target DNA
- 4oo8 - S. pyogenes Cas9 bound to sgRNA and target DNA
- 4cmp
- 4cmq - Mn2+-bound S. pyogenes Cas9
Actinomyces naeslundii Cas9Actinomyces naeslundii Cas9
See AlsoSee Also